Cargando…

Enfermedad de kawasaki

Kawasaki disease is a systemic vasculitis of unknow etiology that occurs predominantly in children under the age of 5 years. Kawasaki disease is the most common cause of acquired heart disease in children in the developed world. The exact cause has not yet been established but there is considerable...

Descripción completa

Detalles Bibliográficos
Autor principal: del Castillo Martín, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Reumatología. Published by Elsevier España S.L. 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147879/
http://dx.doi.org/10.1016/S1577-3566(06)75082-5
_version_ 1783520496143302656
author del Castillo Martín, Fernando
author_facet del Castillo Martín, Fernando
author_sort del Castillo Martín, Fernando
collection PubMed
description Kawasaki disease is a systemic vasculitis of unknow etiology that occurs predominantly in children under the age of 5 years. Kawasaki disease is the most common cause of acquired heart disease in children in the developed world. The exact cause has not yet been established but there is considerable support for it to be due to an infectious agent. The diagnosis of Kawasaki disease is based in clinical criteria: fever persisting at least 5 days and the presence of at least 4 principal features: changes of extremities, polymorphous exanthem, bilateral bulbar conjunctival injection without exudate, changes in lips and oral cavity and cervical lymphadenopathy > 1.5 cm, usually unilateral. The most common complication is coronary arterial aneurysm and coronay arterial dilatation that occurs in 20-25% untreated children. Standard treatment for Kawasaki disease include intravenous immunoglobulin as a single 2 g/kg dose within the first 10 days and oral acetilsalycilic acid. The risk of coronary damage in treated patient is 3-5%.
format Online
Article
Text
id pubmed-7147879
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Sociedad Española de Reumatología. Published by Elsevier España S.L.
record_format MEDLINE/PubMed
spelling pubmed-71478792020-04-13 Enfermedad de kawasaki del Castillo Martín, Fernando Seminarios de la Fundación Española de Reumatología Article Kawasaki disease is a systemic vasculitis of unknow etiology that occurs predominantly in children under the age of 5 years. Kawasaki disease is the most common cause of acquired heart disease in children in the developed world. The exact cause has not yet been established but there is considerable support for it to be due to an infectious agent. The diagnosis of Kawasaki disease is based in clinical criteria: fever persisting at least 5 days and the presence of at least 4 principal features: changes of extremities, polymorphous exanthem, bilateral bulbar conjunctival injection without exudate, changes in lips and oral cavity and cervical lymphadenopathy > 1.5 cm, usually unilateral. The most common complication is coronary arterial aneurysm and coronay arterial dilatation that occurs in 20-25% untreated children. Standard treatment for Kawasaki disease include intravenous immunoglobulin as a single 2 g/kg dose within the first 10 days and oral acetilsalycilic acid. The risk of coronary damage in treated patient is 3-5%. Sociedad Española de Reumatología. Published by Elsevier España S.L. 2006-06 2009-01-06 /pmc/articles/PMC7147879/ http://dx.doi.org/10.1016/S1577-3566(06)75082-5 Text en Copyright © 2006 Sociedad Española de Reumatología. Published by Elsevier España S.L. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
del Castillo Martín, Fernando
Enfermedad de kawasaki
title Enfermedad de kawasaki
title_full Enfermedad de kawasaki
title_fullStr Enfermedad de kawasaki
title_full_unstemmed Enfermedad de kawasaki
title_short Enfermedad de kawasaki
title_sort enfermedad de kawasaki
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147879/
http://dx.doi.org/10.1016/S1577-3566(06)75082-5
work_keys_str_mv AT delcastillomartinfernando enfermedaddekawasaki